To what degree HIV influences the activation profile of MTB-specific CD4+ T-cells as bystander activation or because of the higher pathogen activity associated with HIV infection at, before or after ending TB treatment is currently unclear. The gene discussed is CD4; the disease is HIV infectious disease.